40 Participants Needed

Decision Support for Dementia Caregivers

Recruiting at 4 trial locations
KH
KB
Overseen ByKalisha Bonds Johnson, PhD RN PMHNP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to create and test a program to assist adult daughters in making healthcare decisions for parents with memory loss. It focuses on enhancing the quality of life for African American families dealing with Alzheimer's disease and related dementias. Participants will complete surveys and participate in interviews to explore caregiving experiences and cultural identity. The trial seeks African American daughters and their parents with mild to moderate dementia who are involved in healthcare decision-making. As an unphased trial, this study offers participants the chance to contribute to meaningful research that could improve support for families facing similar challenges.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on decision-making support rather than medication changes.

What prior data suggests that this decision-making program is safe?

Research has shown that dementia programs, like the one in this study, are usually easy for people to use. For instance, a program called WECARE 2.0, designed for Chinese American caregivers, proved simple and accessible for all, regardless of reading level. This suggests that the program in this study is also safe and user-friendly.

Another study examined how dementia programs adapt to different cultures. It found that culturally tailored programs work well and do not cause major problems. Therefore, the program in this study, designed for African American families, is likely safe too.

In summary, these programs for dementia caregivers are generally safe and do not cause serious side effects.12345

Why are researchers excited about this trial?

Researchers are excited about the "Decision Support for Dementia Caregivers" intervention because it focuses on a culturally tailored approach, specifically designed for African-American adult daughters who often shoulder caregiving responsibilities. Unlike typical options that may not address the cultural context or family dynamics, this intervention provides tools for better communication, problem-solving, and navigating the healthcare system within their cultural framework. By integrating these elements, the intervention aims to enhance the caregiving experience and potentially improve outcomes for both caregivers and those living with dementia.

What evidence suggests that this decision-making program is effective for dementia caregivers?

Research shows that a new program, available to participants in this trial, is designed to assist African American families in making healthcare decisions for dementia care. Studies have found that culturally informed programs can enhance communication and problem-solving, particularly between adult daughters and their parents with memory issues. This program considers cultural identity and family relationships, which are crucial for effective caregiving. Evidence suggests that focusing on these areas can lead to better decisions and improved well-being for both caregivers and individuals with dementia. Overall, this approach holds promise for addressing the specific needs of African American families dealing with dementia.26789

Who Is on the Research Team?

KB

Kalisha Bonds Johnson, PhD RN PMHNP

Principal Investigator

Emory University

Are You a Good Fit for This Trial?

This trial is for African American adult daughters aiding their parents with mild to moderate Alzheimer's or dementia. Participants must be able to use email and the internet, speak English, and help with healthcare decisions. Excluded are those with major neurological diseases other than Alzheimer's or severe psychiatric disorders.

Inclusion Criteria

I am an African American caregiver, over 18, helping a loved one with daily tasks and care decisions, and I have internet and email access.
I am an African American, 50 or older, with mild to moderate dementia and can communicate in English.
I am a caregiver with experience in managing healthcare for a parent with dementia.
See 2 more

Exclusion Criteria

PLWD: any confounding significant neurologic diseases or major psychiatric disorder
Caregiver: none specified
Past caregiver: none specified
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (virtual)

Phase 1: Data Collection

Surveys and semi-structured interviews are conducted with adult daughters and parents with memory loss, as well as past caregivers.

Varies per participant
Remote sessions via Zoom

Phase 2a: Prototype Development

Key informants participate in focus group sessions to develop the prototype intervention using design thinking strategies.

3 sessions, 1.5 hours each
Remote sessions via Zoom

Phase 2b: Intervention Testing

Pretest/posttest design with two follow-ups to test the prototype intervention with new dyad participants.

8 weeks
Surveys and interviews

Follow-up

Participants are monitored for retention and usability of the intervention.

3 months
2 follow-up surveys and 1 interview

What Are the Treatments Tested in This Trial?

Interventions

  • Prototype Intervention
Trial Overview The study aims to create a decision-making program tailored for African American families where daughters make healthcare choices for parents with memory loss. It involves surveys/interviews about caregiving experiences and testing a culturally specific prototype intervention.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Prototype InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

A study involving 23 older adults with dementia and 27 family caregivers identified key features that can simplify patient decision aids, such as using clear language, pictograms, and personal stories to enhance understanding and navigation.
The revised decision aids are tailored to better meet the needs of dementia patients and their caregivers, potentially reducing the need for multiple evaluation-modification rounds in the future.
Reducing complexity of patient decision aids for community-based older adults with dementia and their caregivers: multiple case study of Decision Boxes.Bilodeau, G., Witteman, H., Légaré, F., et al.[2023]
The DecideGuide, an interactive web tool for dementia-care networks, was found to be user-friendly for case managers and most informal caregivers, although older users faced challenges with tablet use and the tool's interface needs simplification.
Participants reported that the DecideGuide enhanced their decision-making process by facilitating communication and structuring their thoughts, leading to increased involvement and information sharing among network members.
An Interactive Web Tool for Facilitating Shared Decision-Making in Dementia-Care Networks: A Field Study.Span, M., Smits, C., Jukema, J., et al.[2020]
A survey of 270 health and social care professionals in Northern Ireland revealed that while 86% used numeric information in their practice, they rarely communicated risks using numbers, indicating a gap in effective risk communication in dementia care.
Participants often overestimated the likelihood of serious risks, such as falls and hospitalizations, by significant margins, highlighting the need for improved risk literacy and communication strategies among dementia care practitioners.
Communicating risk in dementia care: Survey of health and social care professionals.Taylor, BJ., Stevenson, M., McDowell, M.[2019]

Citations

Development and evaluation of a healthcare decision ...The purpose of this study was to develop a structured culturally responsive prototype intervention that will improve the healthcare decision-making self- ...
Tailoring and evaluating an intervention to improve shared ...These data will allow us to evaluate whether the intervention changes clinicians' perceptions of being able to adopt shared decision-making ...
(PDF) Development and evaluation of a healthcare ...The purpose of this study was to develop a structured culturally responsive prototype intervention that will improve the healthcare decision- ...
Project Details - NIH RePORTERThis project seeks to identify key factors associated with the formal care decision-making process for African American persons living with ADRD and to improve ...
Health System, Community-Based, or Usual Dementia ...In this randomized clinical trial of dementia care programs, there were no significant differences between a health system–based vs a community-based care ...
New program reduces burnout in dementia caregivers, novel ...WECARE 2.0, a digitally delivered health promotion program for Chinese American dementia caregivers, is easy to use for all literacy levels ...
Cultural Adaptations of Evidence-Based Interventions in ...This review critically evaluated how dementia-related interventions have been culturally adapted and assessed the extent to which these adaptations align with ...
Effectiveness of a health education program for people with ...This study assesses the effectiveness of a health education program on caregiving outcomes for people with dementia and their families.
Supporting decision making for individuals living with ...An intervention to maximize medication management by caregivers of persons with memory loss: Intervention overview and two-month outcomes.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security